The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab (TIS; BGB-A317) plus chemotherapy (CT)/chemoradiotherapy (CRT) as positron emission tomography (PET)–guided neoadjuvant (n) treatment (tx) for resectable esophageal squamous cell carcinoma (R-ESCC): RATIONALE-213 final analysis.
 
Longqi Chen
No Relationships to Disclose
 
Yongde Liao
No Relationships to Disclose
 
Xiaolong Yan
No Relationships to Disclose
 
Mingqiang Kang
No Relationships to Disclose
 
Xinyu Mei
No Relationships to Disclose
 
Lijie Tan
No Relationships to Disclose
 
Junfeng Liu
No Relationships to Disclose
 
Zhang Zhang
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Lei Liang
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Alysha Kadva
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Hongjing Jiang
No Relationships to Disclose